Alexandre Esadze is a Principal Scientist at Pfizer Bacterial Vaccines & Technology, leveraging 12 years of academic research in biochemistry, biophysics, and molecular biology, along with 6 years of industry experience in vaccine development. Alexandre has managed multi-project teams while developing novel protein and RNA-based vaccines and has coordinated regulatory documentation. Their contributions to vaccine characterization have significantly advanced the understanding of antigen-antibody interactions across various diseases, including COVID-19 and Lyme disease. Alexandre's research excellence is highlighted by 25 high-impact publications and several professional awards, including an American Heart Association Grant.
This person is not in any teams
This person is not in any offices